The expression of c-fos was analyzed immunohistochemically after injection of endothelin isopeptide into cerebroventricle of the rat. The c-Fos immunoreactivity increased and reached the peak at 1 hr-1.5 hr after the administration of endothelin. Endothelin-1 and endothelin-2 specifically induced c-fos expression in the neurons of paraventricular, supraoptic and periventricular nuclei and zona incerta. Endothelin-3 induced c-Fos in the organum vasculosum laminae terminalis in addition to those regions.
In these areas, the number of c-Fospositive neurons increased with a dose (O to 100 pg of ET) dependent manner. We presume that they are the targeting neurons of central nervous endothelins (ETs).
I. Introduction
The powerful vasoconstrictor peptide, endothelin (ET), consists of three isopeptides (ET-1, ET-2 and ET-3) and has type A and B receptors.
ET is considered as a vascular peptide" because of its two major biological actions, i.e., regulation of neural transmission and vascular tonus [22] .
The existence of ET in the central nervous system of human and rat was suggested by the radioimmunoassay [6] and Northern blot analysis [14] .Immunohistochemical and in situ hybridization techniques also revealed the distribution of ET in the brain, particularly in hypothalamus [11, 22, 24] . Furthermore, the electrophysiological [23] and pharmacological [3, 15, 19] experiments suggested that the central ET directly acted on the neurons in the centers for blood pressure, water balance and electrolyte metabolism. Some autoradiographic studies only at a low resolution level showed in vitro binding sites for in both rat [2, 8, 10] and human [8] brains. However, in vivo acting sites of central nervous (but not peripheral circulating) ETs have not been obvious.
In rat fibroblasts [17] and vascular smooth muscle cells [9] , ET-1 stimulates the c-fos expression as the result of the increase of intracelluar Ca++. The neurons containing ET-induced c-Fos are considered to be activated by ET directly and/or indirectly. In this study, we used the cFos immunohistochemical method, in order to analyze the distribution of the neurons specifically activated by central ETs. A preliminary report of this work has been presented in abstract form [11] .
II.
Materials and Methods
Animals
The animals used for all experiments were male rats of the Wistar strain weighing 180-220 g, which were purchased from Nippon Clea (Tokyo, Japan) and maintained in the Institute of Experimental Animals of the University under the ethical guidelines for care of animals.
Peptide administration
ET-1, ET-2 and ET-3 (Peptide Institute, Inc., Osaka, Japan) were dissolved in 0.1% acetic acid at a concentration of 1mg/ml.
Ten microliter aliquots were frozen at thawed just before use and diluted to 10 pg, 100 1-C,  D) . In these regions, there were no cells immunopositive for specific c-Fos, at the time immediately (0 min) after any ETinjections. The immunoreactivity was first recognized at 30 min after ET-1, ET-2 or ET-3 administration. The number of positive neurons reached a peak at 1.5 hr to 2 hr after injection of ET (Table 1) , and decreased until 6 hr after injection. From 6 hr to 16 hr after injection, only slight immunopositivity was observed. Then 20 hr later, specific c-Fos could not be detected. No immunopositive neurons were observed in rat forebrain except these hypothalamic nuclei, while only ET-3 induced c-Fos in organum vasculosum laminae terminalis (OVLT) (Fig.  1E) . The c-Fos was not expressed in the other circumventricular organs including the subfornical organ after administration of any ET isopeptides.
In the paraventricular, periventricular and supraoptic nuclei and zona incerta in rats (1.5 hr post-injection time) injected 10 pg of ET-1, several neurons showed immunoreactivity for c-Fos by ET-specific stimulation ( Table  2) . Almost all rats died suddenly after administration of 10 ng ETs. The staining intensity of the individual immunoreactive neurons and the number of the immunopositive neurons was increased with a dose dependent manner (Table 2 ). In the paraventricular nucleus, administration of low dose (1 pg-10 pg) of ET-1, the immunopositive neurons were mainly located in parvocellular part, while the immunopositive neurons were rare in the magnocellular region. However the immunopositive neurons were drastically increased in the magnocellular region with a high dose (100 pg-1 ng). At this dose, about 70% neurons in both parvocellular and magnocellular parts were immunopositive (Fig. 1C) .
Only a few neurons (1 to 3 positive neurons in a section) containing specific c-Fos were observed in the cell nuclei of neurons of paraventricular, periventricular and supraoptic nuclei of hypothalamus, and zona incerta in the animals injected 1 pg of ET-2. The specific c-Fos were found in the rat 1.5 hr after injection of ET-2 (100 pg). In paraventricular nucleus, c-Fos immunopositive neurons induced by ET-2-injection mainly located in parvocellular region (Table 1-2) .
The distributional and dose-dependent patterns of c-Fos immunoreactivity after administration of ET-3 were similar to those obtained by ET-2-injection study, except the paraventricular subnucleus and OVLT. In the paraventricular (both parvocellular and magnocellular parts), periventricular and supraoptic nuclei, a few neurons (3 to 5 positive neurons in a section) containing specific c-Fos were observed in the animals injected 1 pg of ET-3, while several were found in the animals injected 10 pg of ET-3. At every dose, ET-3-injection resulted in much immunopositive neurons than the injection of the same dose of ET-2 ( Table 2) . 
IV. Discussion
Signal transduction mechanism triggered by binding of ET-1 to ET-AR in vascular smooth muscle cells are analyzed intensively [9, 17] . In the vascular smooth muscle cells, the first step of signal transduction is increase of cytosolic Ca++ concentration.
Then, intracellular Ca++ activates the many signal transduction systems including the protein kinase C activation pathway and phosphatidylinositol turnover.
Finally these intracellular signals activate the c-Fos in their cell nucleus to regulate the synthesis of the DNA [9, 17] . Reversely c-fos expression is the result of stimulation of bioactive agents and the increase of the intracellular Ca++. As for the neurons , increase of the intracellular Ca++ is able to excite the neuron, as well as to express the c-fos. Therefore , c-Fos is thought to appear transiently in neurons after monoand/or poly-synaptic, electrical and/or humoral stimulations. Immunohistochemical analysis of specifically triggered c-Fos provided a neuroanatomical technique instead of autoradiography for [14C] 2-deoxyglucose uptake. It has been applied to many in vivo studies for mapping of excited functional pathways in the brain [4, 5, 13] . Although this procedure using c-fos expression is valuable, one weak point is that c-fos is also expressed by nonspecific stimuli (e.g. anesthesia, operation and injection stresses, and spontaneous neural excitation, etc.) [1] . Therefore, the subtraction of these non-specific stimuli from the total c-Fos-immunopositivity is needed. This non-specific c-Fos is observed in the piriform cortex, habenular nucleus and preoptic area in the case of the present study as well as in the previous report [5] .
The immunoreactive neurons increased in number with the injection dose of ET. The least amount of ET-1 or ET-3 for inducing c-Fos antigen in this study, was 1pg, which was less than the tissue content [6] , but was able to excite neurons in an in vitro study [23] . Therefore ET administered into the ventricle in our experiments was considered to be actively concentrated in the proper hypothalamic region under a physiological condition. The ET injection dose for obtaining immunoreactivity of c-Fos was similar to that of other bioactive substances (vasopressin [1] , angiotensin II [7, 12] 
and cholecystokinin
The time course experiments showed that the specific c-Fos was immunohistochemically observed at a slower pace (at least 30 min after injection), but nonspecific (stress-inducible) c-Fos was found in only several minutes and its immunoreactivity reached a peak within less than 30 minutes [18] . In the case of angiotensin II [7] or cholecystokinin [20] , ligand-induced c-Fos immunoreactivity reached a peak at 1.5 hr to 2 hr after the injection. This time course pattern was like that in the case of ET injection.
The distribution of the acting sites of ET in the forebrain has been analyzed by autoradiography using binding [2, 10] . The positive signals were localized in hippocampus, subfornical organ, globus pallidus and caudate-putamen [2] . However, the primary binding site for ET is not thought to correspond to the targeting neural network activated by ET. Moreover, the origin of endogenous ET binding at these regions cannot be distinguished as to whether it is a peripherally circulating or central nervous one. Wall and Ferguson [21] reported that intravenously administered (i.e. peripherally circulating) ET acted on subfornical organ to influence the vasopressin and oxytocin neurons, but not on their neurons directly. By the present study at a cellular level after administration of ET inside of the blood brain barrier, we elucidated that the neural networks activated by ET are in the hypothalamic (paraventricular, periventricular and supraoptic) regions including zona incerta and OVLT. These findings do not contradict the distribution of ET-receptor [11] . Moreover, ET-1 is proved to be biosynthesized in hypothalamic magnocellular neurons Therefore, we presume that ET secreted from magnocellular neurons, acts only on restricted adjacent regions, while circulating ET may act on the circumventricular organ. Thus endothelin, a "brain-vascular peptide", modulates the other neurohormones and transmitters in the central nervous system, and affects directly and/or indirectly the controls of blood pressure, water balance and electrolyte metabolism.
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